Inflectra

Inflectra (generic name: infliximab) is a medication that helps treat certain autoimmune conditions by blocking a protein called tumor necrosis factor-alpha (TNF-alpha), which causes inflammation. It is commonly used for diseases like rheumatoid arthritis, Crohn's disease, and ulcerative colitis. Inflectra is a biosimilar, meaning it is a comparable, typically less expensive version of the original biologic drug. It is administered through injections, usually every few weeks, to help reduce inflammation, alleviate symptoms, and prevent joint or tissue damage, improving quality of life for patients with chronic inflammatory conditions.